Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study

Annals of Oncology

Volumn 9, Issue 1, 1998, Pages 105-108

  Diaz Rubio E ^a   Sastre, J ^a   Zaniboni, A ^b   Labianca, R ^c   Cortes Funes H ^d   De Braud, F ^e   Boni, C ^f   Benavides, M ^g   Dallavalle, G ^c   Homerin, M ^h  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b SPEDALI CIVILI   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h Debiopharm   (France)

Author keywords

Advanced colorectal carcinoma; Oxaliplain; Phase II study

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0004700371     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008200825886     Document Type: Article

References (15)

1. Cohen AM, Minsky BD, Schilsky RL. Colon Cancer. In De Vita VT, Hellman S, Rosenberg SA (eds): Principles and Practice of Oncology. Philadelphia: J.B. Lippincott 1993; 929-77.
2. Moertel CG, Fleming TR, MacDonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
3. Wolmark N, Rockette H, Wickerham L et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 1993; 11: 1879-87.
4. O'Connell MJ, Maillard JA, Kahn MJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246-50.
5. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of Fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 1992; 10: 896-903.
6. Kemeny N, Israel K. Niedzwiecki D et al. Randomized study of continuous infusion fluorouracil vs. fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer. J Clin Oncol 1990; 8: 313-8.
7. TashiroT, Kawada Y, Sakurai Y, Kidani Y. Antitumor activity of a new platinum complex, oxalato (trans-1-1,2-diaminocyclohaxane) platinum (II): New experimental data. Biomed Pharmacother 1989; 43: 251-60.
8. Extra JM, Espie M, Calvo F et al. Phase I study of oxaliplatin in patients with advanced cancer. Cancer Chemother Pharmacol 1990; 25: 299-303.
9. Machover D, Diaz-Rubio E, De Gramont A et al. Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol 1996; 7: 95-8.
10. Levi F, Perpoint B, Garufi C et al. Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulate rate. Eur J Cancer 1993; 29A; 1280-4.
11. Becouarn Y, Ychou M, Ducreux M et al. Oxaliplatin (L-OHP) as first-line chemotherapy in metastatic colorectal cancer (MCRC) patients: Preliminary activity/toxicity. Proc Am Soc Clin Oncol 1997; 16: 229a.
12. Armand JP, Ducreux M, Mahjoubi M et al. CPT-11 (Irinotecan) in the treatment of colorectal cancer. Eur J Cancer 1995; 31A: 1283-7.
13. Rougier P, Bugat R, Douillard JY et al. Phase II of Irinotecan in the treatment of advanced colorectal cancer in chemotherapynaive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 1997; 15: 251-60.
14. Cunningham D, Zalcberg J, Smith IE et al. Tomudex': A novel thymidylate synthethase (TS) inhibitor with clinical antitumour activity in a range of solid tumors. Ann Oncol 1994; 5 (Suppl 8): 179.
15. Cunningham D, Zalcberg J, Rath U et al. Final results of a randomised trials comparing 'tomudex' (ratiltrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Ann Oncol 1996; 7: 961-5.